tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP

Adaptimmune Therapeutics (ADAP) Similar Stocks

Compare
847 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Adaptimmune Therapeutics
$0.58
$148.28M
-58.04%
2 Buy
0 Hold
0 Sell
Moderate Buy
Gilead Sciences
$110.03
$131.17B
276.97
57.37%
18 Buy
7 Hold
0 Sell
Moderate Buy
Bluebird Bio
$7.04
$68.44M
-67.71%
1 Buy
2 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$1.54
$174.26M
-77.38%
3 Buy
2 Hold
0 Sell
Moderate Buy
Iovance Biotherapeutics
$5.61
$1.69B
-64.81%
5 Buy
1 Hold
0 Sell
Strong Buy
Immatics
$4.60
$549.04M
-61.70%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ADAP
Adaptimmune Therapeutics
0.58
-0.92
-61.33%
GILD
Gilead Sciences
110.03
39.70
56.45%
BLUE
Bluebird Bio
7.04
-14.76
-67.71%
FATE
Fate Therapeutics
1.54
-5.29
-77.45%
IOVA
Iovance Biotherapeutics
5.61
-10.16
-64.43%
IMTX
Immatics
4.60
-7.41
-61.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis